KELLNER TED D 4
4 · AIM ImmunoTech Inc. · Filed Apr 23, 2025
Insider Transaction Report
Form 4
KELLNER TED D
Director
Transactions
- Purchase
Common Stock
2025-04-11$0.03/sh+1,968,504$50,000→ 1,969,504 total
Holdings
- 25,000(indirect: By Kellner, Ted Combined Profit Sharing/Money Purchase Plan)
Common Stock
- 1,456,000(indirect: By Kelvest I LP)
Common Stock
- 270,000(indirect: By Beta Fund Investment Club)
Common Stock
Footnotes (5)
- [F1]Shares purchased pursuant to a purchase agreement executed on April 11, 2025, but first required approval from the NYSE American which was received on April 21, 2025.
- [F2]Shares held by Kelvest I LP, for which the reporting person serves as Manager of T&M Partners LLC, General Partner of Kelvest I LP.
- [F3]Shares held by the Beta Fund Investment Club, for which the reporting person serves as the manager and is an investor. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.
- [F4]Shares held by the Kellner, Ted Combined Profit Sharing/Money Purchase Plan, for which the reporting person serves as trustee.
- [F5]Amends prior Form 3 filed by the reporting person with the SEC on 12/23/2024 due to a restructuring of family entities effective April 1, 2025. The reporting person is beneficial owner due to his role as Manager of T&M Partners LLC which serves as General Partner of a newly formed pooled investment vehicle that controls shares of the Company not previously reported on Form 3."